Some visit links earn us a commission.

Mass GIC Medicare GLP-1 coverage in 2027: weight-loss cover ends

By John Samaras, price analyst · Prices checked Nov 16, 2026

Read November 15, 2026 on mass.gov

Massachusetts Group Insurance Commission (GIC) health plans end coverage of GLP-1s prescribed for obesity alone on December 31, 2026 for Medicare plan members. From January 1, 2027 that coverage is gone. Non-Medicare members lost it on June 30, 2026.

What it costs without insurance

If Medicare won't cover it for weight loss

Who this affects

Medicare plan members of GIC health plans who take a GLP-1 for weight loss alone. Members who take one for diabetes are not part of this change.

When it starts

Coverage ends on December 31, 2026. The first day without it is January 1, 2027.

If you lose coverage: cash now

Two cash programs to check.

No insurance needed.

Prices checked Nov 16, 2026.

  1. Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a month
    Check price →Eden's GLP-1 page, then an online assessment
  2. Collective$59 a month, drug pricecompounded semaglutidecompounded tirzepatide $69 a month
    Check price →

What the GIC update says

Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end
  • The GIC dates the end at December 31, 2026 for Medicare plan members and June 30, 2026 for non-Medicare members.
  • In its July 1, 2026 changes the GIC kept coverage for GLP-1s used for diabetes and for members with a BMI of 27 or higher and an FDA-approved comorbidity.
  • Since July 1, 2026, GLP-1 prescriptions go through members' own doctors and need prior authorization through CVS.
  • Vida Health runs through December 31, 2026 without prescribing, for coaching and dietitian visits, and the GIC says it will help members find direct-pay options once coverage ends.
  • CMS says anyone who filled a GLP-1 through a Part D plan in 2026, extra weight-loss coverage included, is not eligible for the Medicare GLP-1 Bridge in 2026. CMS has not yet set its 2027 lookback.

Sources:

What to do before January 1

  • Ask your GIC plan whether your prescription is on file for diabetes or another covered condition before January.
  • Check the Medicare GLP-1 Bridge rules, including the 2027 lookback once CMS sets it.
  • Compare the cash routes on this page before your last covered fill.

The Medicare GLP-1 Bridge in 2027. Medicare GLP-1 Bridge checker.

What cash costs today

Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.

Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.

Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.

Frequently asked questions

When does GIC Medicare stop covering Wegovy for weight loss?
The GIC says coverage of GLP-1s prescribed for obesity alone ends on December 31, 2026 for Medicare plan members.
Did non-Medicare GIC members keep any GLP-1 coverage?
In its July 1, 2026 changes the GIC kept coverage for diabetes and for members with a BMI of 27 or higher and an FDA-approved comorbidity, with prior authorization through CVS.
Can GIC Medicare members use the Medicare GLP-1 Bridge?
CMS says a member who filled a GLP-1 through a Part D plan in 2026 is not eligible in 2026, even through supplemental weight-loss coverage. CMS has not set the lookback it will use in 2027.

Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.